ATE145131T1 - Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung - Google Patents

Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung

Info

Publication number
ATE145131T1
ATE145131T1 AT91303256T AT91303256T ATE145131T1 AT E145131 T1 ATE145131 T1 AT E145131T1 AT 91303256 T AT91303256 T AT 91303256T AT 91303256 T AT91303256 T AT 91303256T AT E145131 T1 ATE145131 T1 AT E145131T1
Authority
AT
Austria
Prior art keywords
coated composition
thermomelting
production
active substance
under heating
Prior art date
Application number
AT91303256T
Other languages
English (en)
Inventor
Norboru Nagafuzi
Takayuki Tsukada
Kazuhiro Shima
Yasushi Takagishi
Yusuke Suzuki
Yoshitaka Tomoda
Takashi Hayashi
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE145131T1 publication Critical patent/ATE145131T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
AT91303256T 1990-04-12 1991-04-12 Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung ATE145131T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9666390 1990-04-12

Publications (1)

Publication Number Publication Date
ATE145131T1 true ATE145131T1 (de) 1996-11-15

Family

ID=14171060

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91303256T ATE145131T1 (de) 1990-04-12 1991-04-12 Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung

Country Status (8)

Country Link
EP (1) EP0452145B1 (de)
JP (1) JP3191948B2 (de)
KR (1) KR0168849B1 (de)
AT (1) ATE145131T1 (de)
DE (1) DE69123075T2 (de)
DK (1) DK0452145T3 (de)
ES (1) ES2096624T3 (de)
GR (1) GR3021606T3 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4217920C2 (de) * 1992-05-30 1996-05-09 Goldwell Gmbh Verfahren zur Herstellung von pulverförmigen Mitteln zum Blondieren von menschlichen Haaren
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JP3466921B2 (ja) * 1998-06-03 2003-11-17 大塚製薬株式会社 味マスキング医薬製剤
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
AT407111B (de) 1998-12-22 2000-12-27 Gergely Dr & Co Zucker- und/oder zuckeralkoholhältiges matrixmaterial und verfahren zu seiner herstellung
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
KR101216270B1 (ko) 1999-10-29 2012-12-31 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP4658306B2 (ja) * 2000-10-18 2011-03-23 ナガセ医薬品株式会社 錠剤用医薬組成物
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
WO2003020241A2 (en) * 2001-09-05 2003-03-13 Vectura Limited Functional powders for oral delivery
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
AU2008246717B2 (en) * 2007-04-26 2013-02-28 Eisai R & D Management Co., Ltd. Method for production of tablet
KR20220124747A (ko) * 2020-03-11 2022-09-14 사와이세이야쿠 가부시키가이샤 과립 및 그것을 이용한 제제
WO2023145865A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用ポリアルキレンオキシド粒子、医薬用組成物、製剤用組成物及び製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5838250A (ja) * 1981-09-01 1983-03-05 Teikoku Chem Ind Corp Ltd 複合体
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
JP2521504B2 (ja) * 1985-12-27 1996-08-07 昭和電工株式会社 酵素の造粒法
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol

Also Published As

Publication number Publication date
DE69123075T2 (de) 1997-03-20
EP0452145B1 (de) 1996-11-13
JP3191948B2 (ja) 2001-07-23
KR910018016A (ko) 1991-11-30
EP0452145A2 (de) 1991-10-16
DK0452145T3 (da) 1996-12-02
JPH04217913A (ja) 1992-08-07
EP0452145A3 (en) 1993-03-10
KR0168849B1 (ko) 1999-01-15
ES2096624T3 (es) 1997-03-16
GR3021606T3 (en) 1997-02-28
DE69123075D1 (de) 1996-12-19

Similar Documents

Publication Publication Date Title
ATE145131T1 (de) Ueberzogene zusammensetzung sowie verfahren zu ihrer herstellung
DE3880762D1 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
HUT43637A (en) Process for producing biologically active new materials and veterinary compositions containing them as active agents, and nematocide insecticide and acaricide compositions containing the above mentioned materials as active agents
ATE7655T1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe und verfahren zu deren herstellung.
UA32406C2 (uk) Пристрій для гоління волосся вологим методом, складовий засіб, що сприяє голінню, та спосіб його виготовлення
DE68910654T2 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung.
DK0624371T3 (da) Mikrokapsler til kontrolleret frigivelse af acetylsalicylsyre
BG103881A (en) Method for the preparation of elurbiprophene pastills
ATE250410T1 (de) Verfahren zur herstellung von wirkstoff- zubereitungen mit kontrollierter freisetzung aus einer matrix
ATE1880T1 (de) Stabile valepotriat-zubereitungen und verfahren zu deren herstellung.
ATE13772T1 (de) Kunstharz-komposition, verfahren zu ihrer herstellung, ihre anwendung und aus der komposition hergestellte folie.
ATA268783A (de) Verfahren zur herstellung von neuen pyridinen und deren aklansaeureestern, methylaethern sowie pharmazeutisch annehmbaren saeureadditionssalzen
ZW17489A1 (en) Curable polymer compositions and their manufacture and use
FR2487707B1 (fr) Composition de liant a base de fulvene, son procede de preparation et son application comme liant de fonderie
ATE40T1 (de) 2-cyclopropyl-pyrimidin(4 )yl-thionophosphonsaeureester, verfahren zu ihrer herstellung, ihre verwendung als insektizide und akarizide, diese enthaltende schaedlingsbekaempfungsmittel und verfahren zu deren herstellung.
AU519360B2 (en) Polymer curing system, air-curable composition and method of preparing the composition
OA06349A (fr) Nouveaux esters phénoxybenzyliques d'acides bromostyrylcyclopanecarboxyliques substitués, leur procédé de production et leur application comme insecticides et acaricides.
JPS5437766A (en) Production of flat optical fiber cables
JPS53149945A (en) Preparation of alpha-phenylpropionic acid derivatives
JPS51119040A (en) Preparation of heat-resistant coating materials
IT8021168A0 (it) Esteri (3-metossicarbonilamminofenilici)dell'acido n-(2-propinil)-carbanilico, procedimento per preparare tali composti nonche' mezzi erbicidi selettivi contenenti gli stessi.
IT8021093A0 (it) Esteri sostituiti dell'acido carbanilico, procedimento di preparazione di tali composti e mezzi erbicidi selettivi contenenti gli stessi.
ATA247380A (de) Verfahren zur herstellung von neuen, 3-substituierten 2-oxo-hexahydro-pyrimido (1,2-a)azepinen sowie von deren pharmazeutisch geeigneten salzen
DD138648A1 (de) Steatitaehnlicher,temperaturwechselbestaendiger,ker&mischer werkstoff und verfahren zu seiner herstellung
AT375937B (de) Verfahren zur herstellung von 9-hydrazono-6,7,8, 9-tetrahaydro-4h-pyrido (1,2-a) - pyrimidin-4-on- derivaten sowie von deren physiologisch vertraeglichen salzen, hydraten und isomeren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee